PBMWW — PSYENCE BIOMEDICAL LTD
As of Q2 2026, 3 SEC-registered investment managers reported holding PBMWW (PSYENCE BIOMEDICAL LTD) in their latest 13F filings, with a combined reported value of $11.17K across 483.47K shares. That is -0.1% by share count (-247 shares) versus the previous quarter, while reported value moved +27.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
PBMWW is classified in the Materials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $4.86K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $3.68K | 0.00% | Hold |
| Millennium Management history | 108.00K | $2.62K | 0.00% | Hold |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $3.64K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $3.17K | 0.00% | Hold |
| Millennium Management history | 108.00K | $1.97K | 0.00% | Hold |
| UBS Group AG history | 247 | $4 | 0.00% | New |
Q4 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $3.71K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $3.45K | 0.00% | Hold |
| Millennium Management history | 108.00K | $2.00K | 0.00% | Hold |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $5.04K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $4.38K | 0.00% | Hold |
| Millennium Management history | 108.00K | $2.72K | 0.00% | Hold |
| UBS Group AG history | 455 | $11 | 0.00% | New |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $4.06K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $3.54K | 0.00% | Hold |
| Millennium Management history | 108.00K | $2.19K | 0.00% | Hold |
Q1 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Goldman Sachs Group history | 200.12K | $3.38K | 0.00% | Hold |
| D. E. Shaw & Co history | 175.35K | $2.96K | 0.00% | Hold |
| Millennium Management history | 108.00K | $1.82K | 0.00% | Hold |
| UBS Group AG history | 1.59K | $27 | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- UBS Group AG sold 247 sh · $4
Fund Position History — shares by quarter (top 4 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Goldman Sachs Group | 200.12K | 200.12K | 200.12K | 200.12K | 200.12K | 200.12K | 200.12K | 200.12K | 200.12K | — |
| D. E. Shaw & Co | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K | 175.35K |
| Millennium Management | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K | 108.00K |
| UBS Group AG | — | 247 | — | 455 | — | 1.59K | — | — | 73 | 73 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details